数据链接：
官方服务：
资源简介：
Enriched pathway in lung adenocarcinoma.
肺腺癌中的富集通路
应用场景：
创建时间：
2015-12-02
相关数据集
TMEM164 promotes ferroptosis by selectively mediating ATG5-dependent autophagosome formation to inhibit the progression of LUAD
The study focuses on lung adenocarcinoma (LUAD), a predominant type of lung cancer. Despite advancements in diagnostics and molecular therapies, treatment remains challenging due to its low five-year
DataCite Commons2024-12-04 更新80
Additional file 2 of A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
Additional file 2: Table S2: The 31 unreported prognostic genes associated with lung adenocarcinoma patients survival.
DataCite Commons2024-02-07 更新60
A comprehensive integrated gene network construction to explore the essential role of Notch 1 in lung adenocarcinoma (LUAD)
The heterogeneous biological landscape of non-small cell lung cancer (NSCLC) is largely attributed to the activation of Notch signalling pathway. Among the Notch family transmembrane proteins, neuroge
Taylor & Francis Group2025-07-16 更新50
RasGRP2 is an emerging reliable biomarker in the immune microenvironment of LUAD based on bioinformatic and experimental analysis.
This link contains all raw data, including public database matrix, raw images, raw data, etc.
DataCite Commons2022-07-07 更新60
Table_9_Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma.xlsx
The RTK/RAS pathway is an oncogenic signaling pathway for which many targeted drugs have been developed; however, survival remains poor. A combination of targeted therapy and immunotherapy has emerged
NIAID Data Ecosystem50
